Simplex Trading’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-4,729
| Closed | -$117K | – | 10123 |
|
|
2026
Q1 | $99.1K | Buy |
+4,729
| New | +$106K | ﹤0.01% | 5105 |
|
|
2025
Q2 | – | Sell |
-23,991
| Closed | -$865K | – | 9552 |
|
|
2025
Q1 | $868K | Buy |
23,991
+18,062
| +305% | +$751K | ﹤0.01% | 2838 |
|
|
2024
Q4 | $249K | Sell |
5,929
-4,418
| -43% | -$219K | ﹤0.01% | 4278 |
|
|
2024
Q3 | $574K | Buy |
10,347
+5,512
| +114% | +$281K | ﹤0.01% | 3452 |
|
|
2024
Q2 | $198K | Buy |
4,835
+3,881
| +407% | +$166K | ﹤0.01% | 4660 |
|
|
2024
Q1 | $44K | Buy |
+954
| New | +$45K | ﹤0.01% | 6376 |
|
|
2022
Q1 | – | Sell |
-94
| Closed | -$6.54K | – | 11215 |
|
|
2021
Q4 | $7K | Sell |
94
-24
| -20% | -$1.95K | ﹤0.01% | 9332 |
|
|
2021
Q3 | $11K | Hold |
118
| – | – | ﹤0.01% | 8882 |
|
|
2021
Q2 | $11K | Sell |
118
-282
| -71% | -$29.4K | ﹤0.01% | 9048 |
|
|
2021
Q1 | $45K | Buy |
+400
| New | +$54.5K | ﹤0.01% | 6743 |
|
|
2020
Q3 | – | Sell |
-23,579
| Closed | -$1.95M | – | 8366 |
|
|
2020
Q2 | $1.84M | Buy |
23,579
+8,294
| +54% | +$549K | ﹤0.01% | 1576 |
|
|
2020
Q1 | $679K | Buy |
15,285
+2,513
| +20% | +$130K | ﹤0.01% | 2277 |
|
|
2019
Q4 | $545K | Buy |
12,772
+1,659
| +15% | +$68.4K | ﹤0.01% | 2660 |
|
|
2019
Q3 | $475K | Buy |
+11,113
| New | +$604K | ﹤0.01% | 2674 |
|
|
2019
Q2 | – | Sell |
-3,593
| Closed | -$229K | – | 7653 |
|
|
2019
Q1 | $249K | Buy |
+3,593
| New | +$205K | ﹤0.01% | 3377 |
|
|
2018
Q4 | – | Sell |
-831
| Closed | -$45.4K | – | 7654 |
|
|
2018
Q3 | $63K | Buy |
+831
| New | +$67.6K | ﹤0.01% | 4937 |
|
|
2018
Q2 | – | Sell |
-2,696
| Closed | -$174K | – | 7795 |
|
|
2018
Q1 | $137K | Buy |
+2,696
| New | +$136K | 0.01% | 1537 |
|
|
2017
Q3 | – | Sell |
-1,441
| Closed | -$85.4K | – | 6497 |
|
|
2017
Q2 | $89K | Sell |
1,441
-6,457
| -82% | -$389K | ﹤0.01% | 1854 |
|
|
2017
Q1 | $535K | Buy |
7,898
+700
| +10% | +$53.3K | 0.02% | 639 |
|
|
2016
Q4 | $506K | Buy |
7,198
+4,580
| +175% | +$325K | 0.03% | 539 |
|
|
2016
Q3 | $185K | Buy |
2,618
+1,451
| +124% | +$92.6K | 0.01% | 1092 |
|
|
2016
Q2 | $57K | Buy |
+1,167
| New | +$75.5K | ﹤0.01% | 1927 |
|
Other funds holding RARE
RI
FCM
Simplex Trading's RARE Position: Q2 2026 in Review
Simplex Trading sold out of Ultragenyx Pharmaceutical (RARE) in Q2 2026, closing a stake of 4,729 shares — an estimated $117K sold.
Simplex Trading first reported a position in RARE in Q2 2016 and held it in 22 quarters. The position peaked at $1.84M in Q2 2020. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.
- Simplex Trading reported no remaining Ultragenyx Pharmaceutical position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 4,729 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $117K.
- Simplex Trading first reported a position in Ultragenyx Pharmaceutical in Q2 2016 and held it in 22 quarters.
- Simplex Trading's Ultragenyx Pharmaceutical position peaked at $1.84M in Q2 2020.
- 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.